| Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised … S Rts Lancet 386 (9988), 31-45, 2015 | 1002 | 2015 |
| First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children RTS, S Clinical Trials Partnership New England Journal of Medicine 365 (20), 1863-1875, 2011 | 985 | 2011 |
| A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants RTS, S Clinical Trials Partnership New England Journal of Medicine 367 (24), 2284-2295, 2012 | 819 | 2012 |
| Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine DE Neafsey, M Juraska, T Bedford, D Benkeser, C Valim, A Griggs, ... New England Journal of Medicine 373 (21), 2025-2037, 2015 | 419 | 2015 |
| Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites RTS, S Clinical Trials Partnership (2014) PLoS medicine 11 (7), e1001685, 2014 | 345 | 2014 |
| Immunogenicity of the RTS, S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial MT White, R Verity, JT Griffin, KP Asante, S Owusu-Agyei, B Greenwood, ... The Lancet infectious diseases 15 (12), 1450-1458, 2015 | 341 | 2015 |
| Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine C Swysen, J Vekemans, M Bruls, S Oyakhirome, C Drakeley, P Kremsner, ... Malaria journal 10, 1-8, 2011 | 83 | 2011 |
| Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya V Thathy, JAM Moulds, B Guyah, W Otieno, JA Stoute Malaria Journal 4, 1-7, 2005 | 82 | 2005 |
| Reduced immune complex binding capacity and increased complement susceptibility of red cells from children with severe malaria-associated anemia BO Owuor, CO Odhiambo, WO Otieno, C Adhiambo, DW Makawiti, ... Molecular Medicine 14, 89-97, 2008 | 69 | 2008 |
| Increased deposition of C3b on red cells with low CR1 and CD55 in a malaria-endemic region of western Kenya: implications for the development of severe anemia CO Odhiambo, W Otieno, C Adhiambo, MM Odera, JA Stoute BMC medicine 6, 1-14, 2008 | 68 | 2008 |
| Long-term incidence of severe malaria following RTS, S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised … H Tinto, W Otieno, S Gesase, H Sorgho, L Otieno, E Liheluka, I Valéa, ... The Lancet Infectious Diseases 19 (8), 821-832, 2019 | 61 | 2019 |
| Risk factors for hypertension among young adults (18-35) years attending in Tenwek Mission Hospital, Bomet County, Kenya in 2018 DO Ondimu, GM Kikuvi, WN Otieno Pan African Medical Journal 33 (1), 2019 | 61 | 2019 |
| Safety profile of the RTS, S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa YG Mendoza, E Garric, A Leach, M Lievens, O Ofori-Anyinam, JY Pirçon, ... Human vaccines & immunotherapeutics, 2019 | 59 | 2019 |
| Health & demographic surveillance system profile: the Kombewa health and demographic surveillance system (Kombewa HDSS) P Sifuna, M Oyugi, B Ogutu, B Andagalu, A Otieno, V Owira, N Otsyula, ... International journal of epidemiology 43 (4), 1097-1104, 2014 | 46 | 2014 |
| Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite … N Otsyula, E Angov, E Bergmann-Leitner, M Koech, F Khan, J Bennett, ... Malaria journal 12, 1-13, 2013 | 43 | 2013 |
| Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care J Vekemans, K Marsh, B Greenwood, A Leach, W Kabore, ... Malaria journal 10, 1-13, 2011 | 38 | 2011 |
| Safety and immunogenicity of RTS, S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial L Otieno, M Oneko, W Otieno, J Abuodha, E Owino, C Odero, ... The Lancet Infectious Diseases 16 (10), 1134-1144, 2016 | 36 | 2016 |
| Distinct pattern of class and subclass antibodies in immune complexes of children with cerebral malaria and severe malarial anaemia EK Mibei, WO Otieno, ASS Orago, JA Stoute Parasite immunology 30 (6‐7), 334-341, 2008 | 34 | 2008 |
| The Levels of CD16/Fcγ Receptor IIIA on CD14+ CD16+ Monocytes Are Higher in Children with Severe Plasmodium falciparum Anemia than in Children with … LA Ogonda, ASS Orago, MF Otieno, C Adhiambo, W Otieno, JA Stoute Infection and immunity 78 (5), 2173-2181, 2010 | 33 | 2010 |
| Host-mediated selection impacts the diversity of Plasmodium falciparum antigens within infections AM Early, M Lievens, BL MacInnis, CF Ockenhouse, SK Volkman, S Adjei, ... Nature communications 9 (1), 1381, 2018 | 24 | 2018 |
Ben AndagaluUnited States Army Medical Research Directorate, KenyaVerified email at usamru-k.org
